Prompt identification of causative pathogenic bacteria is imperative for the treatment of patients suffering from infectious diseases including sepsis and pneumonia. However, current culture-based met
A miniature CRISPR-Cas12f has been demonstrated to serve as an effective genome editing tool in gram negative bacteria as well as human cells. Here, we developed an alternative method to edit the geno
